Citation Impact
Citing Papers
A Novel Method to Assay Herpes Simplex Virus Neutralizing Antibodies Using BHKICP6LacZ-5 (ELVIS™) Cells
1997
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
1989 Standout
Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice
1989
The antiviral activity of antibodies in vitro and in vivo
2001
Toll-like receptor control of the adaptive immune responses
2004 Standout
Mucosal immunity and vaccines
2005 Standout
Characterization of the Effects of Hepatitis C Virus Nonstructural 5A Protein Expression in Human Cell Lines and on Interferon–Sensitive Virus Replication
1999
Human Antibodies from Combinatorial Libraries
1994
Antibody framework residues affecting the conformation of the hypervariable loops
1992 StandoutNobel
Functions of natural killer cells
2008 Standout
Characterization of Events during the Late Stages of HPV16 Infectionin VivoUsing High-Affinity Synthetic Fabs to E4
1997 StandoutNobel
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
1998 Standout
A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection
2018
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.
1994 StandoutNobel
The immunology of stroke: from mechanisms to translation
2011 Standout
Building Antibodies from their Genes
1992 StandoutNobel
Monovalent single‐chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection
1996 StandoutNobel
Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.
1990
A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform 1 1Edited by M. Yaniv
1997 StandoutNobel
Microneedles for drug and vaccine delivery
2012 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge
2010
Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection
1999
Molecular and cellular insights into T cell exhaustion
2015 Standout
Effect of interferon-α and cell differentiation on Puumala virus infection in human monocyte/macrophages
1995
Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes
1983
Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.
1996 StandoutNobel
Altering Genotype and Phenotype by DNA-Mediated Gene Transfer
1980 StandoutScienceNobel
Introduction and expression of a fetal human globin gene in mouse fibroblasts.
1982 StandoutNobel
Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo
1984
Biosynthesis of Human Papillomavirus from a Continuous Cell Line Upon Epithelial Differentiation
1992 Science
Phenotypic Analysis of Antigen-Specific T Lymphocytes
1996 StandoutScience
Induction of mutations within the host cell genome by partially inactivated herpes simplex virus type 1
1982 StandoutNobel
Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus
1988
Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications
1983 Standout
Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with Herpesvirus genetic information
1980 StandoutNobel
Lethal vaccinia infection in cyclophosphamide-suppressed mice is associated with decreased expression of Thy-1, Lyt-2 and L3T4 and diminished IL-2 production in surviving T cells.
1988 StandoutNobel
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
2020 StandoutNobel
Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions
1981 Standout
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes.
1992 StandoutNobel
Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.
1996
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Antiviral Actions of Interferons
2001 Standout
Identification of the stable free radical tyrosine residue in ribonucleotide reductase
1985 StandoutNobel
Is ribonucleotide reductase the transforming function of herpes simplex virus 2?
1983 Nature
Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway.
1992
Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.
1978 StandoutNobel
Human Papillomavirus and Cervical Cancer
2003 Standout
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
2020 StandoutNobel
Resistance to adenovirus infection after administration of Bordetella pertussis vaccine in mice
1985
Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity.
1987 StandoutNobel
Absence of Macrophage Inflammatory Protein-1α Prevents the Development of Blinding Herpes Stromal Keratitis
1998 StandoutNobel
Restriction Endonuclease Fingerprinting of Herpes Simplex Virus DNA: A Novel Epidemiological Tool Applied to a Nosocomial Outbreak
1978
Antiviral Activity of Arabinosylthymine in Herpesviral Replication: Mechanism of Action In Vivo and In Vitro
1977
Relation of Herpes Simplex Viruses to Human Malignancies
1977
Confirmation of Low-Titer, Herpes Simplex Virus-Positive Specimen Results by the Enzyme-Linked Virus-Inducible System (ELVIS) Using PCR and Repeat Testing
1999 StandoutNobel
Herpes Simplex Virus-induced Ribonucleotide Reductase: Development of Antibodies Specific for the Enzyme
1983
Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA.
1977
Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice
1986
Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme.
1983 StandoutNobel
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.
1986
Immunization with nonstructural proteins promotes functional recovery of alphavirus-infected neurons
1997 StandoutNobel
Transformation of mammalian cells with an amplifiable dominant-acting gene.
1980 StandoutNobel
Patterns of Integration of DNA Microinjected into Cultured Mammalian Cells: Evidence for Homologous Recombination Between Injected Plasmid DNA Molecules
1982 StandoutNobel
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2.
1987
The small subunit of ribonucleotide reductase is encoded by one of the most abundant translationally regulated maternal RNAs in clam and sea urchin eggs.
1985 StandoutNobel
Infection with Herpes-Simplex Viruses 1 and 2
1973
Interleukin-12 (IL-12) and IL-18 Are Important in Innate Defense against Genital Herpes Simplex Virus Type 2 Infection in Mice but Are Not Required for the Development of Acquired Gamma Interferon-Mediated Protective Immunity
2001
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Humanized antibodies for antiviral therapy.
1991
Immunological characterization of herpes simplex virus type 1 and 2 polypeptide(s) involved in viral ribonucleotide reductase activity
1984
Selective response of gamma delta T-cell hybridomas to orthomyxovirus-infected cells
1996 StandoutNobel
Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities
1981 StandoutNobel
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Introduction and Expression of a Fetal Human Globin Gene in Mouse Fibroblasts
1982 StandoutNobel
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
Genetic Transformation of Drosophila with Transposable Element Vectors
1982 StandoutScience
Partial purification and characterization of the ribonucleotide reductase induced by herpes simplex virus infection of mammalian cells
1981
Nucleoprotein‐specific nonneutralizing antibodies speed up LCMV elimination independently of complement and F cγR
2013
Works of W E Rawls being referenced
Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
1985
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2
1982
Antigenic Differences between Isolates of Herpesvirus Type 2
1974
Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera
1977
Reactivity between Herpesvirus Type 2-Related Soluble Cervical Tumor Cell Membrane Antigens and Matched Cancer and Control Sera
1972
Antibody responses in humans to individual proteins of herpes simplex viruses
1981
Generation of memory cell-mediated immune responses after secondary infection of mice with pichinde virus.
1984
Herpesvirus type 2-induced thymidine kinase and carcinoma of the cervix.
1974
Characterization of Pichinde virus infection of cells of the monocytic lineage
1991